Banco Bilbao Vizcaya Argentaria’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,362
| Closed | -$208K | – | 710 |
|
|
2025
Q1 | $208K | Buy |
+5,362
| New | +$208K | ﹤0.01% | 709 |
|
|
2024
Q4 | – | Sell |
-5,787
| Closed | -$237K | – | 699 |
|
|
2024
Q3 | $237K | Hold |
5,787
| – | – | ﹤0.01% | 691 |
|
|
2024
Q2 | $223K | Sell |
5,787
-408
| -7% | -$15.7K | ﹤0.01% | 707 |
|
|
2024
Q1 | $266K | Sell |
6,195
-1,670
| -21% | -$71.6K | ﹤0.01% | 726 |
|
|
2023
Q4 | $291K | Sell |
7,865
-600
| -7% | -$22.2K | ﹤0.01% | 694 |
|
|
2023
Q3 | $307K | Sell |
8,465
-382
| -4% | -$13.9K | ﹤0.01% | 679 |
|
|
2023
Q2 | $315K | Buy |
8,847
+1,800
| +26% | +$64.1K | ﹤0.01% | 666 |
|
|
2023
Q1 | $251K | Sell |
7,047
-590
| -8% | -$21K | ﹤0.01% | 684 |
|
|
2022
Q4 | $268K | Hold |
7,637
| – | – | ﹤0.01% | 671 |
|
|
2022
Q3 | $225K | Buy |
+7,637
| New | +$225K | ﹤0.01% | 694 |
|
|
2022
Q2 | – | Sell |
-9,607
| Closed | -$530K | – | 707 |
|
|
2022
Q1 | $530K | Sell |
9,607
-667
| -6% | -$36.8K | 0.01% | 583 |
|
|
2021
Q4 | $567K | Sell |
10,274
-7,416
| -42% | -$409K | 0.01% | 644 |
|
|
2021
Q3 | $846K | Buy |
17,690
+1,622
| +10% | +$77.6K | 0.01% | 530 |
|
|
2021
Q2 | $799K | Buy |
16,068
+9,548
| +146% | +$475K | 0.01% | 555 |
|
|
2021
Q1 | $294K | Sell |
6,520
-1,520
| -19% | -$68.5K | 0.01% | 683 |
|
|
2020
Q4 | $369K | Buy |
8,040
+2,400
| +43% | +$110K | 0.01% | 612 |
|
|
2020
Q3 | $265K | Buy |
+5,640
| New | +$265K | 0.01% | 612 |
|